Yiran Huang

Yiran Huang

Auto-generated profile, based on publicly available information

Yiran Huang

School of Pharmacy, Shenzhen University Medical School, Shenzhen University , Shenzhen 518060

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Bioinformatics
Verified
Journal Article
Open access
YHYiran Huang
Yiran Huang
XTXiao TAN
Xiao TAN
XLXiaoyu Li
Xiaoyu Li
FXFeng Xiong
Feng Xiong
SYSiu Ming Yiu
Siu Ming Yiu
Motivation: DNA-encoded library (DEL) technology has been developed as a powerful platform for drug development. Live cell-based selection methodologies were recently developed to expedite drug candidate discovery with higher biological relevance. Nevertheless, hit characterization is challenged by prominent background signals of cell-based selections. Therefore, automated data processing streamline compatible with noisy sequencing output is highly desirable. Results: Herein, we report an innovative automatic method that enables the most promising hit identification from large quantities of cell-based DEL datasets with improved accuracy and efficiency. This processing workflow is based on a comprehensive unsupervised algorithm incorporating data pre-processing, feature extracting and outlier filtering, descriptor-based classification, similarity score ranking, and active compound prediction. We performed methodology development with two DEL selection datasets targeting insulin receptor (INSR) on live cells, from both ∼30 million- and 1.033 billion-membered libraries. The automated scheme has demonstrated high consistency with experimental results as well as self-adaptivity to on-cell DEL datasets with varied library scales. Extended methodology application to cellular thrombopoietin receptor (TPOR) further substantiated the algorithmic generalization capability regarding target proteins. Thus, this approach can serve as a widely applicable workflow automatically differentiating hit compounds and thereby facilitates drug development from candidate discovery. Availability and implementation: The complete datasets, source code, and pre-trained models are made available at https://doi.org/10.5281/zenodo.17452392 and https://doi.org/10.5281/zenodo.17569557.

1 January 2024
Verified
Book Chapter
Closed access
PDF file
YHY. Huang
Y. Huang
XLX. Li
X. Li
DNA-encoded libraries (DELs) have undergone significant development and are being widely adopted in drug discovery. As part of the evolution of DEL selections, the introduction of the DNA-programmed affinity labelling (DPAL) technique has extended the scope to include more-complex target systems beyond purified proteins immobilized on a solid matrix. In this review, detailed procedures for the application of DPAL-assisted DEL selections are compiled as a guide to the technique. Methods based on selections against in-solution proteins, DNA-encoded dynamic library (DEDL) selections, and selections against membrane proteins on a cell surface are included.

1 January 2024
Verified
Book Chapter
Closed access
PDF file
YZY. Zhou
Y. Zhou
YHY. Huang
Y. Huang
LXL. Xu
L. Xu
FXF. Xiong
F. Xiong
DNA-encoded chemical libraries (DELs) provide a powerful high-throughput screening platform that is used in both academia and industry. High-quality DELs lay the foundation for reliable DEL selection outcomes, and most pharmaceutical companies would prefer double-stranded DELs (dsDELs) because of their superior stability. Here, we summarize the experimental details for encoding a dsDEL, including the overall encoding strategy, synthetic chemistry of building-block addition, ligation strategies of code elongation, and quality control of the resulting libraries, exemplified with a 320-million-membered benzimidazole dsDEL from GlaxoSmithKline (GSK). We also briefly review the successful selection cases involving the presented libraries to highlight the great potential of dsDELs in drug discovery.